President Trump will announce an agreement with Pfizer for the sale of medications at reduced prices, but details about products and applicability remain unclear.

The agreement with Pfizer is part of the Trump administration's strategy to implement the 'most favored nation' model, ensuring that the U.S. pays competitive prices for medications. Pfizer will reduce prices on a large scale and will launch the 'TrumpRx' platform for direct sales to patients. Additionally, the company will invest 70 billion dollars in research and production in the U.S.